Hook & thesis
Red Violet (NASDAQ: RDVT) is an under-the-radar vendor of mission-critical data and identity products that has moved from recovery into true growth. The company reported full-year revenue of $90.3 million and posted a 20% quarter-over-quarter revenue gain to $23.4 million in its most recent fourth quarter. Those top-line gains, combined with positive free cash flow ($27.995 million reported) and a pristine debt picture, argue for a valuation re-rate if execution continues.
Technically, RDVT is trading near its 52-week high ($74.20) after doubling off the March low of $33.40. Momentum indicators (9-day EMA ~$69.97, RSI ~64.4, bullish MACD) all point to continuation rather than a rollover. My actionable stance: take a long position at $73.50 targeting $100.00 over the next 180 trading days, with a protective stop at $66.00.
Why the business matters
Red Violet builds cloud-based, mission-critical information solutions for enterprises across regulated industries. Its brands include IDI (investigative data) and Forewarn (identity verification and safety tools). These are sticky, analytics-heavy products that embed into customer workflows rather than being discretionary spending. That stickiness is reflected in the companys financial profile: profitable on a GAAP basis (recent EPS ~$1.02) and generating positive free cash flow of roughly $28 million.
Enterprises increasingly value real-time identity verification, risk screening, and investigative data as compliance and safety scrutiny rises across industries such as real estate, financial services, and public safety. Red Violets product mix directly addresses those needs, which supports recurring revenue, high retention, and the potential for modest margin expansion as scale improves.
Numbers that matter
- Revenue run-rate context: Q4 revenue was $23.4 million (a 20% increase reported) and full-year revenue was $90.3 million.
- Profitability: reported EPS is ~$1.02; price-to-earnings based on recent price is in the 70x range using the latest quoted price, reflecting growth expectations.
- Valuation & capital structure: market cap ~ $1.18 billion; enterprise value roughly $1.133 billion. Price-to-sales is elevated (~12x) and EV/sales ~11.45x, which is rich versus larger SaaS peers but more defendable given profitability and strong cash generation (free cash flow ~$27.995M).
- Balance sheet: no meaningful debt indicated (debt-to-equity reported as 0) and cash metrics look healthy on a per-share basis; the company closed an underwritten offering of 1,666,667 shares at $60.00 generating $100 million in gross proceeds which adds liquidity for working capital and M&A.
- Technicals & market breadth: 10-day SMA ~$69.23, 50-day SMA ~$63.09; recent price action sits near the 52-week high of $74.198 after rallying from a $33.40 low on 03/30/2026. Short interest has trended down from ~888k to ~597k with days-to-cover near ~3.2, reducing the immediate squeeze risk.
Valuation framing
At a market cap of ~$1.18 billion and trailing revenue near $90 million, RDVT trades at roughly 11-12x revenue. That multiple is clearly premium for a sub-$100M revenue company but should be judged against two offsets: first, the business is already profitable and producing free cash flow (~$28M); second, growth is real (20% reported in the latest quarter). If Red Violet can sustain mid-teens revenue growth while converting a stable portion to free cash flow, the market could reasonably justify step-ups in valuation. A move to a $100 share price implies a market cap near $1.61 billion (16.11M shares outstanding x $100), which would still be within a premium-but-not-absurd range for a profitable, growing data company with acquisition optionality funded by the recent capital raise.
Catalysts (what to watch)
- Quarterly results beating revenue or margin expectations; further proof of sustained 15-20% top-line growth would validate the premium multiple.
- Evidence that the $100M gross proceeds from the 08/07/2026 offering are being deployed accretively - tuck-in M&A or product expansion could materially increase addressable market per customer.
- Contract wins or expanded deployments at enterprise customers for Forewarn and IDI (examples: larger MLS integrations, financial institution pilots, or government contracts).
- Continued improvement in operating margins and free cash flow conversion from incremental revenue.
- Positive reception at investor events and conferences (management presentations have occurred at B. Riley and Needham events earlier in the year), which can help re-rate smaller, less-followed names.
Trade plan
Entry: $73.50
Stop loss: $66.00
Target: $100.00
Risk level: medium
Trade direction: long
Horizon: long term (180 trading days). I expect this trade to play out over several quarters as top-line momentum, margin expansion, and the deployment of recent capital become visible to the market. The 180-day window allows for one or two quarterly reports and time for any announced M&A to begin to show pro forma benefits.
Rationale: enter near current market levels to capture momentum and position ahead of the next two earnings cycles. The stop at $66.00 is set below near-term moving averages and recent support to limit downside if momentum falters. The target to $100 assumes continued execution and a multiple re-rating aligned with profitable growth and improved investor attention.
Risks & counterarguments
- Dilution & capital deployment risk: The 1,666,667 share offering at $60 closed on 08/07/2026, creating dilution risk and raising investor questions about why cash was needed. If proceeds are used for non-accretive purposes, the re-rate thesis weakens.
- Valuation premium: At ~11-12x sales and a high tepid PE in the 60-70x range, RDVT is priced for strong execution. Any slip in growth or margin guidance could lead to a sharp de-rating.
- Concentration & customer risk: Mission-critical products can still be concentrated in verticals. Large customer churn or delayed enterprise rollouts would hit revenue disproportionately.
- Liquidity & volatility: Average trading volume measures are mixed (multi-source averages vary), and intraday liquidity can be thin; this can amplify moves on news and complicate exits.
- Macro / discretionary spend pullback: While identity and safety tools are sticky, a broad tech or spending pullback could delay renewals or new deployments.
Counterargument: skeptics will point to the high revenue multiple and insist the company is richly valued for its size. That argument has merit - RDVT must keep delivering 15-20% growth and margin improvement to justify a premium multiple. If revenue growth moderates to single digits, the premium valuation will be hard to sustain and a different trade (or short) would be warranted.
Conclusion - what would change my mind
My base case is a long bias into $100 over 180 trading days assuming Red Violet sustains growth, converts revenue into cash, and deploys the $100M raise in ways that increase addressable market or margins. I would change my view if any of the following occur: an earnings print that shows revenue deceleration below mid-teens growth, management signals that the capital raise will fund near-term cash burn rather than accretive M&A, or customer churn spikes. Conversely, I would add to the position if management announces a clear accretive acquisition, or if the company posts a quarter with both revenue and free cash flow materially ahead of Street expectations.
Bottom line: RDVT is a profitable, cash-generative niche data vendor trading at a premium but with credible growth drivers and a recently strengthened liquidity position. For disciplined, growth-oriented investors willing to tolerate elevated multiples, initiating a controlled long position at $73.50 with a stop at $66.00 and a target of $100.00 over the next 180 trading days is a sensible way to play the thesis.